A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis

<div>S100A12 levels at 2<sup>nd</sup> time point depending on (a) systemic GCS intake within the observation period and (b) intraarticular GCS injection at 1<sup>st</sup> time point. GCS: glucocorticosteroids.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis 

Figure 2 | A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis 